Cosentyx is a biologic medication that is used to treat various inflammatory conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis. According to the drug patent watch website [1], Cosentyx is a prescription drug that is available in two formulations: 150 mg/mL and 75 mg/mL. The recommended dosage of Cosentyx varies depending on the condition being treated and the patient's weight. The drug is administered by subcutaneous injection, and the frequency of administration can also vary depending on the condition being treated.

The Cosentyx website [2] provides information on how often the medication can be adjusted. According to the website, the dosage of Cosentyx can be adjusted based on the patient's response to treatment. If the patient's symptoms improve, the dosage may be decreased to 75 mg/mL. If the patient's symptoms worsen or do not improve, the dosage may be increased to 300 mg/mL. However, any adjustments to the dosage should be made under the guidance of a healthcare provider.

A study published in the Journal of Clinical Medicine [3] evaluated the efficacy and safety of Cosentyx in patients with ankylosing spondylitis. The study found that patients who received Cosentyx had significant improvements in their symptoms compared to those who received a placebo. The study also found that the dosage of Cosentyx could be adjusted based on the patient's response to treatment.

In conclusion, the dosage of Cosentyx can be adjusted based on the patient's response to treatment. The frequency of administration and the dosage amount can vary depending on the condition being treated and the patient's weight. Any adjustments to the dosage should be made under the guidance of a healthcare provider.

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX
[2] https://www.cosentyx.com/ankylosing-spondylitis/faq
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935619/